These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 13793331)

  • 1. Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    Surgery; 1959 Dec; 46():1060-8. PubMed ID: 13793331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of heparin effects by protamine sulfate].
    GERENDAS M
    Orv Hetil; 1956 Jan; 97(5):113-8. PubMed ID: 13335127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Practical problems raised by the neutralization of heparin in surgery. Simple technic for the evaluation of the neutralization dose of protamine].
    RABY C; BOURDET P; CHAMBRETTE B; ESPINASSOUZE G
    Sem Hop Ther Paris; 1962 Jun; 38():504-8. PubMed ID: 14489667
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of effects of protamine and polybrene, with special emphasis on the factor VIII (antihemophilic globulin) deficiency induced.
    PERKINS HA; HARKINS G; GERBODE F; ROLFS MR; ACRA DJ
    J Clin Invest; 1961 Aug; 40(8 Pt 1-2):1421-30. PubMed ID: 13734399
    [No Abstract]   [Full Text] [Related]  

  • 5. The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.
    EGERTON WS; ROBINSON CL
    Lancet; 1961 Sep; 2(7203):635-7. PubMed ID: 13725907
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
    Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
    Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of heparin neutralization and the danger of blood clotting abnormalities with protamine and polybrene.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    J Thorac Cardiovasc Surg; 1960 May; 39():613-8. PubMed ID: 13793330
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest.
    Godal HC; Gjengedal G
    Scand J Haematol; 1971; 8(3):194-9. PubMed ID: 5093996
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 15. Does protamine chloride neutralize low molecular weight heparin sufficiently?
    Gram J; Mercker S; Bruhn HD
    Thromb Res; 1988 Dec; 52(5):353-9. PubMed ID: 2851882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two heparin-neutralizing agents: protamine and polybrene.
    GODAL HC
    Scand J Clin Lab Invest; 1960; 12(4):446-57. PubMed ID: 13706163
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the inactivation of the antiheparin effect of protamine sulfate].
    MASELLI CAMPAGNA G; PACCIONE F; VAILATI G; RUBINO M
    Boll Soc Ital Biol Sper; 1962 Jul; 38():661-4. PubMed ID: 14470761
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 19. The nature of the anticoagulant effect of heparin, protamine, polybrene and toluidine blue.
    OLLENDORFF P
    Scand J Clin Lab Invest; 1962; 14():267-76. PubMed ID: 14481859
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.